Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
45.62%
↑ 256% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-29.15%
Historical baseline
PeriodValue
202545.62%
20246.26%
2023-27.47%
2022-1.04%
2021-83.46%
2020-76.96%
2019-96.14%
20180.00%